X

Posts

April 03, 2014

+
4:00 PM | ALS Treatment (in Cells) – Too Late for Glenn, But Wonderful News
I was cutting and pasting a post about Sunday night’s episode of Call the Midwife, which was about cystic fibrosis, when a news release came in that brought me to tears. Kevin Eggan and co-workers at the Harvard Stem Cell Institute have discovered that the seizure drug Potiga (retigabine), FDA-approved in 2010, apparently tempers the hyperexcitability of neurons derived from induced pluripotent stem (iPS) cells made from patients who have amyotrophic lateral sclerosis (ALS).… Read […]
+
12:55 PM | FDA Releases Draft Guidance Concerning Distribution of Off-Label Medical Device Data
Unapproved or off-label use of medical devices is an issue that manufacturers must face with a carefully-planned strategy in order to avoid running afoul of FDA regulations. In an effort to make sure that companies don’t stray too far when discussing off-label use with physicians and other healthcare professionals, the FDA has released a new draft guidance ... continue reading
+
12:00 PM | Building Computer Circuits from Slime
It might sound like science fiction, but researchers are actually exploring how to make computer circuits using slime molds. Why slime molds? It turns out that while slime molds don’t have a brain or even a nervous system, they’re able to make chemical-based decisions, and this behavior can be utilized to make some basic circuit … Continue reading »
+
11:33 AM | What’s the Answer? (PPI images in compartments)
BioStar is a site for asking, answering and discussing bioinformatics questions and issues. We are members of the community and find it very useful. Often questions and answers arise at BioStar that are germane to our readers (end users of genomics resources). Every Thursday we will be highlighting one of those items or discussions here […]
+
10:18 AM | Europe votes for greater clinical trial transparency
European Parliament passes new EU Clinical Trials Regulation
+
10:17 AM | Pharma paid £38.5m to UK healthcare professionals in 2013
Slight decrease on 2012 figures
+
9:56 AM | Merck KGaA and Pfizer collaborate on lupus
Companies team up with academics to research treatments for autoimmune disorder
+
9:29 AM | Astellas uses animated bladder in campaign
Character in US advertisement for Myrbetriq constantly interrupts a woman with overactive bladder
+
8:49 AM | Neurons Definition and Function of Neurotransmitters
Neurons are specialized nerve cells (also see neural cells) and responsible for relaying information via neurotransmitter release. A human brain consists of well over 100 billion neurons. A neuron is the basic building foundation of the human nervous system. Anatomy of a Neuron – VIDEO Messages for other cells or between neurons are sent across synapses in the […] The post Neurons Definition and Function of Neurotransmitters appeared first on Regeneration Center of […]
+
2:21 AM | Q&A about Plenish® soybeans
In the post What do you want to know about Plenish® Soybeans? we invited you to ask questions of Susan Knowlton, a Senior Research Manager with DuPont and the lead of the DuPont Healthy Oils team (see her bio below). Dr. Knowles has provided detailed responses to some of your questions. 1. Will this oil be available to the general consumer, and if so, how will we be able to tell it comes from these soybeans? Plenish high oleic soybean oil will initially be made available to food […]

April 02, 2014

+
11:15 PM | Red Door appoints Dinning to lead youth engagement
Former Phoenix Consultancy managing director appointed head of new outreach programme
+
11:01 PM | Tonix appoints head of clinical development
Donald Kellerman has experience at Allergan, Map, Inspire and Glaxo Wellcome
+
11:01 PM | Losing the plot?
Influencing beliefs over branding
+
7:58 PM | The Hunter and the Bear: Italy’s Stamina and Vannoni, as Aesop would have told it
Editor’s note: Some of the links included are Italian language sources The case involving Stamina Foundation and the legitimacy of its stem cell treatments has been one of the most discussed and controversial issues in the international stem cell policy scene. Tomorrow, April 3, Davide Vannoni, Stamina’s founder, will be expected at a court trial...Read more
+
6:05 PM | The E. Coli Ballad
Tweet This Post
+
5:23 PM | Scientist Said He May Have Made STAP Cells—Just As Riken Called Fraud
claimtoken-5350a6c03d880 In light of a press conference yesterday announcing two counts of deliberate misconduct, Riken Institute brass want co-authors of the Nature “acid bath” stem cell papers to retract one—after appeal. But two developments may complicate this. First, lead author Haruko Obokata refuses to accept it.Read more about Scientist Said He May Have Made STAP Cells—Just As Riken Called FraudComments
+
3:37 PM | Do lemurs like to move it-move it? (Video)
Lemurs had their 15 minutes of fame, back when DreamWork’s Madagascar came out in 2005. This year it’s time for IMAX Island of Lemurs: Madagascar to shine a spotlight on this primates. We discussed before how nature documentaries influence the … Continue reading →
+
1:58 PM | Culture Rules- Investigating Company Cultures
When searching for a job it’s important to consider the job duties as well as the company and the company’s culture. Two companies have become famous for their cultures—Google and Zappos. Google is known as a company where you work hard in an amazing environment. Oh, and the food is free! Zappos is known as […]
+
1:37 PM | Video Tip of the Week: EuPathDB
I love pathogens and parasites. Really, I do. I mean–not up very close. But their astonishing range and cleverness often earns my respect. How these small organisms can wreak havoc on larger systems, inveigle the larger organisms to fly, carry, or ship them around during appropriate points in their life cycle, and to cloak themselves […]

Aurrecoechea C., Brestelli J., Brunk B.P., Fischer S., Gajria B., Gao X., Gingle A., Grant G., Harb O.S. & Heiges M. & (2009). EuPathDB: a portal to eukaryotic pathogen databases, Nucleic Acids Research, 38 (Database) D415-D419. DOI:

Citation
+
10:22 AM | Scientific ink slinger for hire – enquire within
As of April 1st, I have cut loose from the ties of salaried employment and dived into the exciting world of freelance writing. Crazy, I know. Since it’s only been a day, I’m not going to tell you about the experience so far. This is, in fact, a publicity exercise.  First, let me tell you that […]
+
10:09 AM | Global pancreatic cancer market to treble in value
Celgene's Abraxane will drive rapid growth over next three years
+
10:05 AM | GSK terminates lung cancer vaccine trial
Unable to identify patients who may benefit from MAGE-A3 immunotherapy
+
9:54 AM | Icon boost medical device trial capability with Aptiv acquisition
Deal will also enhance the CRO's position in adaptive trials and in Japan
+
9:48 AM | Lilly thrown a lifeline on US Alimta patent
Court backs protection from generics until 2022
+
8:53 AM | MannKind's inhaled insulin backed for US approval
Afrezza finally on course for FDA approval in diabetes after two rejections
+
6:03 AM | Epic Video Games for Science
Do you feel like this when you sit down to write a science paper, write a peer review or analyze your science experiment results? What if you could feel like this instead? As it turns out, video games are not a waste of time. In fact, if you talk to Jane McGonigal, world-renowned designer of alternate reality games, video games might be enabling the young and old alike to solve society’s most pressing problems, from climate change, to energy crises,... Read more

April 01, 2014

+
11:15 PM | Pharma must step up monitoring of social media
New service intends to help keep track of online patient communications
+
11:15 PM | MHRA chairman steps down
Sir Gordon Duff leaves to join Oxford University
+
11:01 PM | Developing your patient-centric strategy
How to succeed when your vehicle of engagement is not a disease
+
9:21 PM | Controversial biotech outreach program gets mixed reception
By Abril D Primero The Biotechnology industry, struggling to gain acceptance for their products, has looked at social media as a wild animal they’ve been unable to tame, until now. Momsanto, a giant corporation that sells genetically engineered seeds and low-calorie sweeteners, has launched a program called “$hill Bucks.” This new social media-based incentive program, the industry believes, will allow them to regain control of public opinion, which according to online comment […]
34567891011
318 Results